Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...
Osivax, a FRance-based biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly...
Moderna, Inc. has announced that the Taiwan Food & Drug Administration (FDA) has approved an updated formulation of ...
Q: The usage of messenger RNA (mRNA) as novel active ingredient has attracted public attention in recent years, ...
Danish firm Bavarian Nordic A/S has announced that Singapore’s medicines regulatory authority, Health Sciences Aut...
A new facility at The University of Queensland (UQ) is set to provide Australian researchers with cancer vaccines tailor...
Korea's Ministry of Health and Welfare and the Korea Health Industry Development Institute (KHIDI) recent...
SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a Simple Agreement for F...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and French biotech firm Valneva SE, have expanded th...
Mélanie Joly, Canada’s Minister of Foreign Affairs, visited the International Vaccine Institute’s (IV...
Indian Immunologicals Ltd (IIL), led by its Chairman Dr Meenesh Shah and Managing Director Dr K. Anand Kumar, has donate...
Moderna, Inc. and Mitsubishi Tanabe Pharma Corporation have entered into a joint agreement regarding the co-promot...
Merck, a leading science and technology company, has announced that its life science business sector has entered a...
South Korea-based International Vaccine Institute (IVI) has signed a memorandum of understanding (MoU) with the Catholic...
Gavi, the Vaccine Alliance, in collaboration with partners, has announced support for human rabies vaccines for post exp...
The International Vaccine Institute (IVI) has exchanged a trilateral Memorandum of Understanding (MoU) with the Korea Ad...
Queensland will be a major international hub for vaccine discovery and development with a $32 million partnership secure...
A scientific team from the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) and Mo...
Bavarian Nordic A/S and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced a partnership to advan...
Singapore's Ministry of Health has announced that Novavax/Nuvaxovid XBB.1.5 COVID-19 vaccine will be available under the...
Under the esteemed patronage of the Ministry of National Guard Health Affairs, represented by the Infection Prevent...
GSK's Arexvy has been approved by the Health Sciences Authority (HSA) of Singapore for active immunisation for...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...
An international consortium of researchers developing a vaccine against troublesome COVID-19 variants will receive addit...
American firm Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, has...
WestGene, a China-based biotech company dedicated to mRNA technology, has announced a historic milestone with the US FDA...
The SARS CoV-2 infection can cause a wide range of recurring or persistent health concerns among the populations infecte...
American firm Pfizer Inc. has announced that the Hong Kong Department of Health (DH) has granted marketing authorisation...
A research team from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) has developed ...
EuBiologics and the International Vaccine Institute (IVI), based in South Korea, have announced that Euvichol-S, an impr...
India-based Bharat Biotech, a global leader in vaccine and biotherapeutic innovation, also the largest manufacturer of o...
WHO has launched a new network for coronaviruses, CoViNet, to facilitate and coordinate global expertise and capacities ...
Two Chinease firms, Jiangsu Recbio Technology Co., Ltd. and Shanghai Rongsheng Biotech Co.,Ltd. have partnered to l...
Under the terms of the agreement, Univercells will test in vitro and in vivo a proprietary mRNA vacc...
SK bioscience has shipped approximately 440,000 doses of SKYCellflu to Biogenetech in Thailand from its v...
South Korea-based International Vaccine Institute (IVI) has commenced a technology transfer of simplified Oral Cholera V...
At the mRNA Technology Transfer Program organized by the World Health Organization (WHO) and Medicines Patent Pool (MPP)...
The Bill & Melinda Gates Medical Research Institute (Gates MRI) has announced that a Phase 3 clinical trial to asses...
There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published in The...
A top-ranking public research university in Belgium has received funding from Norway-based Coalition for Epidemic Prepar...
SK bioscience, South Korea-based vaccine and biotech company, has broken ground on a major expansion of its vaccine manu...
Scientists in the US are set to test a new vaccine approach that could overcome some of the challenges associated with t...
The China Association for Science and Technology (CAS) Consortium of Life Sciences Societies is proud to announce the ...
Japan's NEC Corporation, AI and digital tech firm along with Transgene, which develops virus-based immunotherapies for c...
South Korea-based International Vaccine Institute (IVI) will open a Country and Project Office in Kenya dedicated to the...
Medidata, a subsidiary of Dassault Systèmes, a leading provider of clinical trial solutions for the life sciences...
South Korea-based International Vaccine Institute (IVI), and the Ministry of Health of Rwanda have announced that IVI wi...
Japanese pharmaceutical company Takeda has announced a strategic partnership with Biological E, a le...
SK bioscience, a South Korea-based vaccine and biotech company, has obtained prequalification (PQ) certification from th...
US-based VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and t...
The 16th Obstetrics and Gynaecology Conference took place on 30 January under the theme ‘From evidence to practice...
GSK Australia has received Therapeutic Goods Administration (TGA) approval of AREXVY (respiratory syncytial virus v...
Singapore-based Zuellig Pharma has announced its commercialisation partnership with French pharmaceutical company Substi...
A team of scientists, led by Singapore’s Duke-NUS Medical School, has discovered a potential intranasal vaccine ca...
Norway-based Coalition for Epidemic Preparedness Innovations(CEPI) has partnered with Lemonex Inc. (Lemonex), a bi...
The International Vaccine Institute (IVI) and EuBiologics Co have announced the licensure for export by the Korean Minis...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and US-based nonprofit global health organisation&nb...
American firm Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, h...
Denmark-based Novo Nordisk Foundation is committing up to DKK 1.8 billion ($260 million) to establish a state-...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with Korea’s Chungbuk National U...
South Korea-based DxVx will conduct its own clinical trials of OVM-200, an anti-cancer vaccine from Oxford Vacmedix (OVM...
Thailand's Chulalongkorn University and the University of Sheffield, England, have signed an academic cooperation agreem...
The International Vaccine Institute (IVI) and the Korea Advanced Institute of Science and Technology (KAIST) have signed...
South Korea-based SK bioscience has entered into a development licensing agreement with Hilleman Laboratories, in Singap...
The University of Hong Kong (HKU), the University of Cambridge (UCAM), and the International Vaccine Institute (IVI) hav...
South Korea-based International Vaccine Institute (IVI) and Bio Farma, a biotechnology company based in West Java, Indon...
The US Food and Drug Administration (FDA) has approved Ixchiq, the first chikungunya vaccine, developed by Valneva ...
On 9 November, Hilleman Laboratories opened its ACES current Good Manufacturing Practices (cGMP) facility in Singapore w...
Four vaccine hubs have received a share of £33 million of UK aid funding via the Department of Health and Soc...
The Netherlands Ministry of Health, Sports and Welfare has announced an additional EUR 14 million contribution to Norway...
South Korea-based SK bioscience recently announced that Dr Jean Kaseya, Director General, African Centers...
South Korea-based International Vaccine Institute (IVI) has partnered with KEMRI-Wellcome Trust Research Programme (KWTR...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and American firm Moderna, Inc. have entered into ...
Australia-based Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation fro...
As the world is progressively rebounding from pandemic impact, Moderna is constantly developing next-generation combinat...
The Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and the Roya...
The Ministry of Health and Welfare in South Korea has announced that the Ministry and the Asian Development Bank (ADB) a...
A novel glycoengineering platform, created by the researchers at Yong Loo Lin School of Medicine, National University of...
British pharmaceutical firm GlaxoSmithKline (GSK) has reached an exclusive agreement with Chongqing Zhifei Biologic...
At the recently held 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundati...
The Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, and the Institut Pasteur de Dakar (IPD...
Dr Deckster Tonny SAVADYE, CEO of Zimbabwe National Biotechnology Authority (NBA), and Dr Yang Yili, Internati...
UK-based Emergex Vaccines Holding has signed a Memorandum of Understanding with the Saudi Arabia-based startup Vaccine I...
Sanofi, one of the world’s leading healthcare companies, has progressed its partnership with Griffith University b...
Japan-based pharmaceutical company Takeda has announced that the World Health Organization’s (WHO) Strategic Advis...
British pharma firm GlaxoSmithKline (GSK) has announced that Japan’s Ministry of Health, Labour and Welfare (...
The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway, and Indonesia-based company Bio Farma have en...
South Korea-based International Vaccine Institute (IVI), an international organisation with a mission to discover, devel...
Clover Biopharmaceuticals has announced the launch of AdimFlu-S (QIS) in mainland China, where it is the only imported q...
South Korea-based SK bioscience has announced that Ana Brnabić, Prime Minister of the Republic of Serbia (Serbia) visit...
South Korea-based International Vaccine Institute (IVI), EuBiologics, and DEK Vaccines have signed a Memorandum of Under...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Insti...
South Korea-based International Vaccine Institute (IVI), an international organisation with a mission to discover, devel...
South Korea-based GC Biopharma has signed a Memorandum of Understanding (MoU) with Eubiologics (also based in South Kore...
Scientists led by a team from Duke-NUS Medical School in Singapore have identified three distinct serotypes of SARS-rela...
South Korea-based SK bioscience has entered into a collaboration agreement with Vaxxas, an Australian biotechnology comp...
Japan-based Nagasaki University and NEC OncoImmunity (NOI), a leading artificial intelligence (AI) company, will c...
US-based Arcturus Therapeutics Holdings Inc., has announced that ARCALIS Co., its manufacturing joint venture in Japan t...
Australia's University of Adelaide researchers have started work on developing a new vaccine that could help ward off pa...
South Korea-based SK bioscience, an innovative vaccine and biotech company, has decided to make an equity investment in ...
